News RSS
Supporting community response and resilience during COVID-19 (Updated 25th March)
COVID-19 has exposed and deepened the inequality between the less fortunate and privileged ones. The evolving COVID-19 situation has affected...
Flowflex achieved the highest number of regulatory approvals globally
Asia• Pre-market approval in Singapore • Self-testing approval in Singapore, Malaysia, China, Thailand, Vietnam, Philippines, Indonesia, Myanmar, Brunei Europe• CE-Mark for self-testing•...
HSA has announced that Flowflex and SD Biosensor supplied in Singapore is not affected by US FDA advisory on unauthorised versions
In late 2021, when FlowFlex became one of the first few brands that have achieved FDA EUA, traders in Europe...
University of Geneva evaluates several ARTs against Omicron and Delta variants
FlowFlex has a sensitivity of 91.2% against the Delta and 88.9% against the Omicron. Standard Q has a sensitivity of...
TGA approved Flowflex Antigen Rapid Test for supply in Australia
The TGA has approved the Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing) for supply in Australia from 1 November 2021. The TGA's...
- Choosing a selection results in a full page refresh.
- Press the space key then arrow keys to make a selection.
- Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device